title: Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease.
abstract: OBJECTIVE
  To compare plasma adiponectin levels between healthy controls and patients with chronic renal failure and to examine for a relationship between plasma adiponectin levels and ischemic heart disease as well as aortic distensibility which is an early marker of atherosclerosis.
  
  
  METHODS
  We included 89 patients with CRF (45 on and 44 not on hemodialysis) and 70 controls in a cross-sectional study. Plasma adiponectin levels were measured by radioimmunoassay. Aortic distensibility was assessed by high-resolution ultrasonography.
  
  
  RESULTS
  Plasma adiponectin levels were significantly almost twice as high in patients with renal failure compared to controls (9.7 +/- 1.1 vs. 5.4 +/- 0.6 microg/ml, p < 0.0001). No significant differences were found between renal patients on hemodialysis and not on hemodialysis (p = 0.71). Multivariate linear regression analysis in the renal patient group demonstrated a significant negative relationship between plasma adiponectin levels and ischemic heart disease (p = 0.02). The same analysis in the control subjects group showed a significant, negative relationship between plasma adiponectin levels and body mass index (p = 0.02) and a highly significant positive relationship with the high density lipoprotein cholesterol (p < 0.0001). In the total study population, glomerular filtration rate was the only independent predictor of plasma adiponectin concentrations. Aortic distensibility was lower in renal patients than in controls at a high level of significance (p < 0.0001). However, no significant relationship could be found between plasma adiponectin and aortic distensibility in either the controls or the renal patients.
  
  
  CONCLUSIONS
  Plasma adiponectin levels are almost twice as high in patients with chronic renal failure in comparison with healthy controls, but not different between renal patients on and those not on hemodialysis. In addition, low plasma adiponectin levels are strongly associated with ischemic heart disease, but not with aortic distensibility in chronic renal failure.
authors.affiliation: 1st Department of Propedeutic Medicine, Athens University Medical School, 115 21 Athens, Greece.
authors.forename: N
authors.initials: N
authors.lastname: Tentolouris
authors.forename: D
authors.initials: D
authors.lastname: Doulgerakis
authors.forename: I
authors.initials: I
authors.lastname: Moyssakis
authors.forename: D
authors.initials: D
authors.lastname: Kyriaki
authors.forename: K
authors.initials: K
authors.lastname: Makrilakis
authors.forename: G
authors.initials: G
authors.lastname: Kosmadakis
authors.forename: D
authors.initials: D
authors.lastname: Stamatiadis
authors.forename: N
authors.initials: N
authors.lastname: Katsilambros
authors.forename: C
authors.initials: C
authors.lastname: Stathakis
mesh_terms: D052242:Adiponectin; D000328:Adult; D000368:Aged; D015992:Body Mass Index; D008078:Cholesterol, LDL / Q000097:blood; D003430:Cross-Sectional Studies; D005260:Female; D005919:Glomerular Filtration Rate; D006461:Hemolysis; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D007676:Kidney Failure, Chronic / Q000097:blood*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000209:etiology*; D012044:Regression Analysis; D012307:Risk Factors
chemical_list: D052242:Adiponectin; D008078:Cholesterol, LDL; D036341:Intercellular Signaling Peptides and Proteins